These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1424 related articles for article (PubMed ID: 25884842)
1. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors. Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity. Gatti M; Solari A; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Würth R; Corsaro A; Bajetto A; Ratto A; Ferrari A; Daga A; Barbieri F; Florio T Exp Cell Res; 2018 Feb; 363(1):48-64. PubMed ID: 29305964 [TBL] [Abstract][Full Text] [Related]
3. Isolation of stem-like cells from spontaneous feline mammary carcinomas: phenotypic characterization and tumorigenic potential. Barbieri F; Wurth R; Ratto A; Campanella C; Vito G; Thellung S; Daga A; Cilli M; Ferrari A; Florio T Exp Cell Res; 2012 Apr; 318(7):847-60. PubMed ID: 22366263 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells. Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286 [TBL] [Abstract][Full Text] [Related]
6. The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells. Vazquez-Martin A; Oliveras-Ferraros C; Del Barco S; Martin-Castillo B; Menendez JA Breast Cancer Res Treat; 2011 Apr; 126(2):355-64. PubMed ID: 20458531 [TBL] [Abstract][Full Text] [Related]
7. New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate. Cui J; Hollmén M; Li L; Chen Y; Proulx ST; Reker D; Schneider G; Detmar M Oncotarget; 2017 Jan; 8(1):1007-1022. PubMed ID: 27894093 [TBL] [Abstract][Full Text] [Related]
8. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer. Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735 [TBL] [Abstract][Full Text] [Related]
9. Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts. Cufi S; Corominas-Faja B; Vazquez-Martin A; Oliveras-Ferraros C; Dorca J; Bosch-Barrera J; Martin-Castillo B; Menendez JA Oncotarget; 2012 Apr; 3(4):395-8. PubMed ID: 22565037 [TBL] [Abstract][Full Text] [Related]
10. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs. Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463 [TBL] [Abstract][Full Text] [Related]
11. Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas. Martin-Castillo B; Lopez-Bonet E; Cuyàs E; Viñas G; Pernas S; Dorca J; Menendez JA Oncotarget; 2015 Oct; 6(32):32317-38. PubMed ID: 26474458 [TBL] [Abstract][Full Text] [Related]
12. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant. Farnie G; Sotgia F; Lisanti MP Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710 [TBL] [Abstract][Full Text] [Related]
13. Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs. Ning X; Du Y; Ben Q; Huang L; He X; Gong Y; Gao J; Wu H; Man X; Jin J; Xu M; Li Z Cell Cycle; 2016; 15(3):403-12. PubMed ID: 26709750 [TBL] [Abstract][Full Text] [Related]
14. Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047. Cirenajwis H; Smiljanic S; Honeth G; Hegardt C; Marton LJ; Oredsson SM Anticancer Drugs; 2010 Nov; 21(10):897-906. PubMed ID: 20838207 [TBL] [Abstract][Full Text] [Related]
15. PGE Lin MC; Chen SY; He PL; Herschman H; Li HJ Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109 [TBL] [Abstract][Full Text] [Related]
16. Canine osteosarcoma cell lines contain stem-like cancer cells: biological and pharmacological characterization. Gatti M; Wurth R; Vito G; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Villa V; Corsaro A; Nizzari M; Bajetto A; Ratto A; Ferrari A; Barbieri F; Florio T Jpn J Vet Res; 2016 May; 64(2):101-12. PubMed ID: 27506084 [TBL] [Abstract][Full Text] [Related]
17. The potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study. Huang J; Zhang D; Xie F; Lin D J Vet Sci; 2015; 16(2):225-31. PubMed ID: 26124697 [TBL] [Abstract][Full Text] [Related]